Literature DB >> 1706557

Acidic fibroblast growth factor (aFGF) is present in the fluid of brain tumour pseudocysts.

J R Moringlane1, R Spinas, P Böhlen.   

Abstract

Fluid samples from brain tumour pseudocysts were examined for the presence of Fibroblast Growth Factor (FGF). Fluids were collected from 6 patients with differentiated low grade gliomas (group A), 3 anaplastic gliomas (group B) and 3 metastases (group C). For FGF assays pooled fluids from group A, B, and C were subjected to affinity chromatography on a Heparin-Sepharose column. Each pool contained endothelial cell mitogenic activity which eluted in the 1.2 M NaCl fraction and to a lesser degree in the 0.6 M fraction of Heparin-Sepharose high affinity chromatography. Mitogenic activity in the 1.2 M NaCl fraction of Heparin-Sepharose chromatography suggests the presence of acidic FGF (aFGF).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1706557     DOI: 10.1007/bf01405785

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  42 in total

Review 1.  Vascular structures in brain tumors.

Authors:  A Hirano; T Matsui
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

2.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

3.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.

Authors:  D Gospodarowicz; J Cheng; G M Lui; A Baird; P Böhlent
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Authors:  D T Connolly; D M Heuvelman; R Nelson; J V Olander; B L Eppley; J J Delfino; N R Siegel; R M Leimgruber; J Feder
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Endothelial growth factor present in tissue culture of CNS tumors.

Authors:  P J Kelly; R L Suddith; H T Hutchison; K Werrbach; B Haber
Journal:  J Neurosurg       Date:  1976-03       Impact factor: 5.115

6.  Cyst fluids of malignant human brain tumors contain substances that stimulate the growth of cultured human gliomas of various histological type.

Authors:  M Westphal; H Nausch; H D Herrmann
Journal:  Neurosurgery       Date:  1989-08       Impact factor: 4.654

7.  Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography.

Authors:  R R Lobb; J W Fett
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

8.  Thymidine kinase in brain-tumor cysts.

Authors:  L Persson; J Boethius; J S Gronowitz; C Källander; L Lindgren
Journal:  J Neurosurg       Date:  1985-10       Impact factor: 5.115

9.  Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response.

Authors:  A Baird; N Ling
Journal:  Biochem Biophys Res Commun       Date:  1987-01-30       Impact factor: 3.575

Review 10.  The biology of malignant gliomas--a comprehensive survey.

Authors:  R D McComb; D D Bigner
Journal:  Clin Neuropathol       Date:  1984 May-Jun       Impact factor: 1.368

View more
  3 in total

Review 1.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

2.  Migration of human glioma cells in response to tumour cyst fluids.

Authors:  A Giese; F Schröder; A Steiner; M Westphal
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid.

Authors:  M Nistér; P Enblad; G Bäckström; T Söderman; L Persson; C H Heldin; B Westermark
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.